BNIP3 and cancer: In the first experimental approach adopted, the electroporation of a shBNIP3-GFP plasmid vector into the skeletal muscle successfully knocked down BNIP3 protein levels in healthy control mice but was ineffective in C26 hosts, where the cancer-induced BNIP3 overexpression was not abrogated with this gene transfer technique.